Pub. Date : 2019
PMID : 31696059
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center. | crizotinib | ALK receptor tyrosine kinase | Homo sapiens |
| 2 | Methods: We reviewed the medical records of crizotinib-treated NSCLC patients with ALK-rearrangement between May 2014 and May 2018 at Fudan University Shanghai Cancer Center. | crizotinib | ALK receptor tyrosine kinase | Homo sapiens |
| 3 | Conclusions: Crizotinib was effective and well tolerated in Chinese patients with ALK-positive, advanced NSCLC in real-world clinical practice. | crizotinib | ALK receptor tyrosine kinase | Homo sapiens |